148 related articles for article (PubMed ID: 30575210)
1. Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.
Tahara T; Tahara S; Horiguchi N; Okubo M; Terada T; Yamada H; Yoshida D; Omori T; Osaki H; Maeda K; Kamano T; Funasaka K; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
Hum Mutat; 2019 Mar; 40(3):347-354. PubMed ID: 30575210
[TBL] [Abstract][Full Text] [Related]
2. Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.
Tahara T; Shibata T; Okamoto Y; Yamazaki J; Kawamura T; Horiguchi N; Okubo M; Nakano N; Ishizuka T; Nagasaka M; Nakagawa Y; Ohmiya N
Oncotarget; 2016 Jul; 7(27):42252-60. PubMed ID: 27323394
[TBL] [Abstract][Full Text] [Related]
3. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
[TBL] [Abstract][Full Text] [Related]
5. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract][Full Text] [Related]
6. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features.
Park SY; Kook MC; Kim YW; Cho NY; Jung N; Kwon HJ; Kim TY; Kang GH
Virchows Arch; 2010 Oct; 457(4):415-22. PubMed ID: 20737169
[TBL] [Abstract][Full Text] [Related]
7. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.
Chen HY; Zhu BH; Zhang CH; Yang DJ; Peng JJ; Chen JH; Liu FK; He YL
Cancer Sci; 2012 Jan; 103(1):73-9. PubMed ID: 22017425
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
[TBL] [Abstract][Full Text] [Related]
9. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
10. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features.
Tahara S; Tahara T; Yamazaki J; Shijimaya T; Horiguchi N; Funasaka K; Fukui T; Nakagawa Y; Shibata T; Naganuma M; Tsukamoto T; Ohmiya N
Mol Carcinog; 2024 Feb; 63(2):266-274. PubMed ID: 37846801
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
14. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer.
Tahara S; Tahara T; Horiguchi N; Okubo M; Terada T; Yoshida D; Funasaka K; Nakagawa Y; Shibata T; Tsukamoto T; Ohmiya N
Epigenomics; 2019 Nov; 11(15):1651-1659. PubMed ID: 31701771
[No Abstract] [Full Text] [Related]
15. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF
Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae.
Enomoto S; Maekita T; Tsukamoto T; Nakajima T; Nakazawa K; Tatematsu M; Ichinose M; Ushijima T
Cancer Sci; 2007 Dec; 98(12):1853-61. PubMed ID: 17900260
[TBL] [Abstract][Full Text] [Related]
17. Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.
Padmanabhan N; Kyon HK; Boot A; Lim K; Srivastava S; Chen S; Wu Z; Lee HO; Mukundan VT; Chan C; Chan YK; Xuewen O; Pitt JJ; Isa ZFA; Xing M; Lee MH; Tan ALK; Ting SHW; Luftig MA; Kappei D; Kruger WD; Bian J; Ho YS; Teh M; Rozen SG; Tan P
Genome Biol; 2021 Jun; 22(1):167. PubMed ID: 34074348
[TBL] [Abstract][Full Text] [Related]
18. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
Bae JM; Kim JH; Kang GH
Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
